You are here: Home » Markets » News
Business Standard

Rossari Biotech surges 18% in 2 days after Plutus Wealth acquires stake

The stock was trading at its highest level since its listing on July 23, 2020

Topics
Rossari Biotech | Buzzing stocks | Markets

SI Reporter  |  Mumbai 

Following the sharp run-up, returns are expected to plateau.

Shares of shot up 5 per cent to Rs 859 on the National Stock Exchange (NSE) on Thursday after Plutus Wealth Management LLP acquired 3 lakh shares of the company at Rs 773.82 per share.

The stock has gained 18 per cent in the last two trading days. It was trading at its highest level since its listing on July 23, 2020. The market price of has more-than-doubled against its issue price of Rs 425 per share.

On Wednesday, September 2, Plutus Wealth Management LLP bought 300,000 equity shares of specialty chemicals maker at Rs 773.82 per share on the NSE, the bulk deal data shows. The name of sellers was not ascertained immediately.

raised Rs 496 crore thorough initial public offer (IPO), which had received massive investor interest with the IPO getting subscribed 79.37 times.

Rossari Biotech is into acrylic polymer business, which finds application into the home & personal care along with paints. The management highlighted that they have witnessed decent traction from the home & personal care products due to the Covid-19. The company has return ratios in the high thirties.

For the April-June quarter (Q1FY21), Rossari Biotech reported 419 basis points margin improvement primarily on account of higher realisations witnessed in certain product categories and is transitory in nature. So, going forward, the management expects to report normalized margins on an annual basis.

At 09:35 am, the stock was trading 2 per cent higher at Rs 834 on the NSE, as compared to 0.23 per cent rise in the Nifty 50 index. A combined 1.2 million equity shares have changed hands on the counter on the NSE and BSE, so far.

Dear Reader,


Business Standard has always strived hard to provide up-to-date information and commentary on developments that are of interest to you and have wider political and economic implications for the country and the world. Your encouragement and constant feedback on how to improve our offering have only made our resolve and commitment to these ideals stronger. Even during these difficult times arising out of Covid-19, we continue to remain committed to keeping you informed and updated with credible news, authoritative views and incisive commentary on topical issues of relevance.
We, however, have a request.

As we battle the economic impact of the pandemic, we need your support even more, so that we can continue to offer you more quality content. Our subscription model has seen an encouraging response from many of you, who have subscribed to our online content. More subscription to our online content can only help us achieve the goals of offering you even better and more relevant content. We believe in free, fair and credible journalism. Your support through more subscriptions can help us practise the journalism to which we are committed.

Support quality journalism and subscribe to Business Standard.

Digital Editor

First Published: Thu, September 03 2020. 09:42 IST
RECOMMENDED FOR YOU
.